Iconic Labs PLC

("Iconic" or the "Company")

Restoration of Trading and Funding Update

Iconic Labs PLC (LSE:ICON) has requested the Financial Conduct Authority to lift the suspension of the listing of the Company's Ordinary Shares and as a result, shareholders can once again trade in the Company's shares on the London Stock Exchange as of 20 May 2025.

The Directors will continue to search for a new acquisition target and will update the market when it is in a position to do so. 

As at 30 April 2025, Iconic had around £100,000 of external trade creditors/accrued expenses.  ABO, the Company's key funding partner, through its WTGO fund, has confirmed that they will fund this amount and continue to fund Iconic on a rolling three-month basis as Iconic searches for alternative acquisition targets.

In the event that a target cannot be identified in a reasonable time frame, it is possible that the Company's investor, ABO, will cease to provide such funding.  Although the Directors would endeavour to pursue alternative sources of funding, there is no certainty that this would be achieved. In such an event Iconic would need to wind down its operations, realise any assets and may enter administration, if and to the extent there are creditors of the Company who cannot be paid. In such an event, Iconic would no longer manage its affairs or the realisation of its assets. As a result of either winding down the business or entering into administration, the Ordinary Shares would be cancelled from the Official List and Shareholders may receive little or no value for their Ordinary Shares.

- Ends -

For more information, please contact: